Stocks · News reference

BioRestorative Therapies Says Lance Alstodt Resigns As President, CEO, Chairman And All Other Positions Effective July 13, 2026; Robert Kristal Resigns As CFO And All Other Positions; Katharyn Field Appointed As CEO, President, And Interim CFO

Jul 16, 2026, 9:45 PMBenzinga Newsdesk

https://ir.biorestorative.com/sec-filings/all-sec-filings/content/0001493152-26-033593/form8-k.htm

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

SEC EDGARAug 25, 2026, 9:00 PMSEC EDGAR
8-K filing — BioRestorative Therapies, Inc. (BRTX)
Filed: 2026-08-25 AccNo: 0001213900-26-093566 Size: 193 KB Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Item 9.01: Financial Statements and Exhibits
Read original at edgar
BRTX
BenzingaAug 14, 2026, 8:48 PMBenzinga Newsdesk
Biorestorative Therapies Suspends All Orders, Shipments Of ExoCR, BioX Biocosmeceutical Product Lines Effective Immediately, On Aug 7; Conducting Review Of The Documentation, Sourcing, Regulatory Status Associated With Suspended Products; Has Not Made Decision To Discontinue Suspended Product Lines
On August 7, 2026, BioRestorative Therapies, Inc. (the "Company") suspended, effective immediately, all orders and shipments of its biocosmeceutical product lines, consisting of its ExoCR products and its BioX
Read original at benzinga
BRTX
BenzingaAug 7, 2026, 9:05 PMBenzinga Insights
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers AbCellera Biologics (NASDAQ:ABCL) shares increased by 8.2% to $7.5 during Friday's after-market session. The company's market cap stands at $1.9 billion. As per the news, the Q2 earnings report came out
Read original at benzinga
ABCL AKAN BRTX HIND ICCM